Journal: Cell Death & Disease
Article Title: LincRNA-EPS alleviates osteoclastogenesis under inflammatory microenvironment through preventing excessive iron metabolism
doi: 10.1038/s41419-026-08716-y
Figure Lengend Snippet: A Efficiency of lincRNA-EPS overexpression in WT OCPs ( n = 3). B Lcn2 gene expression (left panel), Lcn2 protein expression (middle panel) and secretion (right panel) post-overexpression after LPS stimulation ( n = 3). C Intracellular Fe 2+ levels detected by FerroOrange probe ( n = 3). Scale bar: 10 μm. D Expression of iron metabolism-related genes post-overexpression after LPS stimulation ( n = 3). E Expression of iron metabolism proteins and osteoclastogenesis key proteins after lincRNA-EPS overexpression( n = 3). F TRAP staining showing the osteoclast differentiation after lincRNA-EPS overexpression. Scale bar: 20 um. The number of osteoclasts, the maximal nuclei count and the maximum diameter were analyzed ( n = 3). G The expression of osteoclastogenesis genes after lincRNA-EPS overexpression ( n = 3). Two-way ANOVA with Tukey-Kramer test was used in A , B , D , E , G . Unpaired t -test was used in C and F . Data were presented as mean ± SD. Significance levels were denoted as follows: * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns refers to no significant difference. In D , G , significance levels were also denoted as a ( P < 0.05), b ( P < 0.01), c ( P < 0.001) and d ( P < 0.0001) when compared with the same group at “LPS-” timepoint.
Article Snippet: Following lentivirus were purchased from OBiO Technology (Shanghai) Corp., Ltd: lincRNA-EPS overexpression lentivirus (pASLenti-pA-Ttc39aos1-CMV-EF1-EGFP-WPRE) and negative control (pASLenti-pA-MCS-CMV-EF1-EGFP-WPRE), Lcn2 knockdown lentivirus (pCLenti-U6-shRNA(Lcn2)-CMV-EGFP-WPRE) and negative control (pCLenti-U6-shRNA(NC)-CMV-EGFP-WPRE).
Techniques: Over Expression, Gene Expression, Expressing, Staining